TY  - GEN
AU  - Makhoul,Issam
AU  - Todorova,Valentina K
AU  - Siegel,Eric R
AU  - Erickson,Stephen W
AU  - Dhakal,Ishwori
AU  - Raj,Vinay R
AU  - Lee,Jeannette Y
AU  - Orloff,Mohammed S
AU  - Griffin,Robert J
AU  - Henry-Tillman,Ronda S
AU  - Klimberg,Suzanne
AU  - Hutchins,Laura F
AU  - Kadlubar,Susan A
TI  - Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients
SN  - 1932-6203
PY  - 2017///0821
KW  - Adult
KW  - Aged
KW  - Angiopoietin-1
KW  - genetics
KW  - Angiopoietin-2
KW  - Bevacizumab
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Clinical Trials, Phase II as Topic
KW  - Ethnicity
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Matrix Metalloproteinase 9
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neovascularization, Pathologic
KW  - Observational Studies as Topic
KW  - Polymorphism, Single Nucleotide
KW  - Prospective Studies
KW  - Receptor, TIE-2
KW  - Regression Analysis
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1371/journal.pone.0168550
ER  -